Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
15.16
+0.05 (0.33%)
May 22, 2025, 11:58 AM - Market open
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $389.44 million as of May 22, 2025. Its market cap has decreased by -2.22% in one year.
Market Cap
389.44M
Enterprise Value
139.04M
1-Year Change
-2.22%
Ranking
Category
Stock Price
$15.16
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $389.44M, an increase of 75.68%. That is a compound annual growth rate of 42.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 388.15M | -25.36% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.69B |
| Johnson & Johnson | 369.57B |
| AbbVie | 325.74B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 291.33B |
| Abbott Laboratories | 235.39B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |